http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016152926-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_474c0f6a4c2cbf4e0aaec9d352d184f2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2007-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1435
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1492
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
filingDate 2016-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27f27b8125c0460f6e243c2fcf55c322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_616c79300feec6d48e5bc1b014d98aa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8747ab1f3bcc9696400c2da202b7d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb3c760e6daa5742857032ec231c8137
publicationDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2016152926-A
titleOfInvention Systems, devices, and methods for tissue treatment and stenosis control
abstract Systems, delivery devices, and methods for treating tissue to ablate, damage, or otherwise affect the tissue are provided. The treatment system can deliver a coolable ablation assembly that ablates the target tissue without damaging the non-target tissue. The coolable ablation assembly damages neural tissue so as to temporarily or permanently reduce nervous system input. Systems, delivery devices, and methods can damage tissue and, if present, manage scarring and stenosis. [Selection] Figure 8
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020026217-A1
priorityDate 2009-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456601273

Total number of triples: 33.